Predictive Factors for the Success of Rehabilitation Programs in Chronic Low Back Pain
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Jul 1, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to predict which patients with chronic low back pain will benefit most from rehabilitation programs. Chronic low back pain is pain that lasts for three months or more and can make daily activities very difficult. Although many treatments exist, it’s often hard to know in advance which ones will work best for each person. This study aims to find specific signs or “biomarkers” that can help doctors understand who is likely to improve with a combination of physical exercises, psychological support, and other therapies.
To join this study, you must be an adult with chronic low back pain lasting at least three months, able to give informed consent, and covered by health insurance. People currently involved in certain other medical studies, those with serious psychiatric or cancer conditions, or who are pregnant or breastfeeding, cannot participate. Participants will take part in a rehabilitation program that includes physical, psychological, and professional care designed to help manage pain and improve daily functioning. The goal is to better tailor treatments to each person’s needs and improve long-term recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with chronic low back pain ≥ three months
- • The patient must have given their free and informed consent and signed the consent form
- • The patient must be a member or beneficiary of a health insurance plan
- Exclusion Criteria:
- • The patient is participating in a category 1 interventional study, or a study on a medication or medical device without prior approval of the primary investigator
- • The patient is in a period of exclusion determined by a previous study
- • It is impossible to give the subject informed information
- • The patient is under safeguard of justice or state guardianship
- • Patient followed or treated for a psychiatric, cancerous or orthopedic pathology that risks modifying their course of care
- • Pregnant, parturient or breastfeeding patient.
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Nîmes,, Gard, France
Nîmes, Occitanie, France
Clermont Ferrand, Auvergne, France
Montpellier, Occitanie, France
Patients applied
Trial Officials
Arnaud Dupeyron
Principal Investigator
CHU de Nimes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported